--Canadian private equity fund Brookfield Asset Management has resumed talks with Spanish pharmaceutical company Grifols over a potential takeover bid, five months after dropping out of a first set of negotiations to acquire Grifols, Spain's news website El Confidencial reports, citing unnamed sources.
--The new bid would be for a 7 billion purchase price, El Confidencial writes, citing the same sources.
--Brookfield's general director, Tristan Tully, is holding the talks with the Grifols family through Morgan Stanley, and has requested more detailed information about the producer of plasma-derived medicines, the article says.
--Grifols declined to comment to El Confidencial.
Full story in Spanish: https://tinyurl.com/3f48nxny
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 04:44 ET (08:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。